MedTrace Logo

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

NCT00358345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 347

Last updated 2008-01-15

No results posted yet for this study

Summary

The primary objective of this study is to assess the ability of the PreView PHP(study device)to detect newly diagnosed non-treated Choroidal Neovascularization (CNV)lesion associate with advanced Age-related Macular Degeneration (AMD) or Myopia and differentiate them from Intermediate AMD or Geographic Atrophy (GA)or patients with high Myopia with no CNV.

This study secondary is to enhance NotalVision normative database.

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Ofer Sharon, MD · Notal Vision

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2007-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00358345 on ClinicalTrials.gov